44 Economists Answer Questionnaire on the Pre-Market Approval of Drugs and Devices

Jason Briggeman, Daniel Klein and Kevin D. Rollins

Econ Journal Watch, 2010, vol. 7, issue 2, 162-173

Abstract: In the January 2010 issue of this journal, we called, by name, 305 health economists to answer, without anonymity, an online interactive questionnaire about the pre-market approval of drugs and devices, and about the existence of a market-failure rationale for the policy. Of those called, 44 individuals participated. Here we summarize their answers to the closed-end questions and provide full transcripts of all the virtual conversations. We do not respond to or evaluate the responses. The 44 respondents come from 12 countries. Most of the respondents hold academic positions, but others are in government, industry, the non-profit health sector, and private research/consultancy. Link to this report's appendix which contains the 44 transcripts

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://econjwatch.org/File+download/431/Briggeman ... 010.pdf?mimetype=pdf (application/pdf)
https://econjwatch.org/660 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ejw:journl:v:7:y:2010:i:2:p:162-173

Access Statistics for this article

Econ Journal Watch is currently edited by Daniel Klein

More articles in Econ Journal Watch from Econ Journal Watch Contact information at EDIRC.
Bibliographic data for series maintained by Jason Briggeman ().